Your browser doesn't support javascript.
loading
A MRI-based radiomics model for predicting the response to anlotinb combined with temozolomide in recurrent malignant glioma patients.
Li, Yurong; Xu, Weilin; Fei, Yinjiao; Wu, Mengxing; Yuan, Jinling; Qiu, Lei; Zhang, Yumeng; Chen, Guanhua; Cheng, Yu; Cao, Yuandong; Zhou, Shu.
Afiliação
  • Li Y; The First School of Clinical Medicine, Nanjing Medical University, Nanjing, China.
  • Xu W; The Second Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China.
  • Fei Y; Department of Radiation Oncology, Nanjing Medical University First Affiliated Hospital, Nanjing, China.
  • Wu M; Department of Radiation Oncology, Nanjing Medical University First Affiliated Hospital, Nanjing, China.
  • Yuan J; The First School of Clinical Medicine, Nanjing Medical University, Nanjing, China.
  • Qiu L; Department of Radiation Oncology, Nanjing Medical University First Affiliated Hospital, Nanjing, China.
  • Zhang Y; The First School of Clinical Medicine, Nanjing Medical University, Nanjing, China.
  • Chen G; Department of Radiation Oncology, Nanjing Medical University First Affiliated Hospital, Nanjing, China.
  • Cheng Y; The First School of Clinical Medicine, Nanjing Medical University, Nanjing, China.
  • Cao Y; Department of Radiation Oncology, Nanjing Medical University First Affiliated Hospital, Nanjing, China.
  • Zhou S; Department of Radiation Center, Shanghai First Maternity and Infant Hospital, Tongji University School of Medicine, Shanghai, 201204, China.
Discov Oncol ; 14(1): 154, 2023 Aug 23.
Article em En | MEDLINE | ID: mdl-37612579
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Tipo de estudo: Prognostic_studies / Risk_factors_studies Idioma: En Revista: Discov Oncol Ano de publicação: 2023 Tipo de documento: Article País de afiliação: China
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Tipo de estudo: Prognostic_studies / Risk_factors_studies Idioma: En Revista: Discov Oncol Ano de publicação: 2023 Tipo de documento: Article País de afiliação: China